Dr. Mario Flores, D.O. Pain Medicine - Interventional Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 21634 Retreat Pkwy, Temescal Valley, CA 92883 Phone: 951-683-6370 |
News Archive
Today, the Federal Court in Australia published its judgment in the Peterson case. The Court found against MSD Australia on two claims under Australian statutory provisions. The Court dismissed all claims against Merck & Co., Inc. specifically finding that Merck was not negligent in its development, scientific study and sale of Vioxx. Merck and MSD Australia disagree with the limited portions of the Court's findings that were against MSD Australia and intend to appeal them.
A new study has estimated the financial impact of poor mental health on the West Midlands region to be over £12 billion per year, including nearly £2 billion a year as a direct cost to the NHS - equivalent to more than £3000 for every person living in the area.
Omeros Corporation announced that OMS824, its phosphodiesterase 10 inhibitor, has received orphan drug designation from the U.S. Food and Drug Administration for the treatment of Huntington's disease.
New cocaine and cannabis research reveals that regular cannabis users have increased levels of impulsive behaviour. It had previously been argued that this increased impulsivity after cannabis administration was only experienced by occasional users, but that regular users were no longer affected in this way.
TheraVida, Inc., a clinical stage biopharmaceutical company developing novel combination drug products, today presented positive results from a Phase 1 clinical trial of its lead product candidate THVD-201 for the treatment of overactive bladder and urge urinary incontinence.
› Verified 4 days ago